The effects of heparin coating of oxygenator fibers on platelet adhesion and protein adsorption.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Anesthesia and Analgesia

• Publication date

  1999-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00000539-199909000-00006PMID 10475283
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit

  2004cited by this paper
• The Inflammatory Response to Cardiopulmonary Bypass

  1996cited by this paper
• Clinical Study of Platelet Function and Coagulation/ Fibrinolysis With Duraflo II Heparin Coated Cardiopulmonary Bypass Equipment

  1996cited by this paper
• Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.

  1996cited by this paper
• Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.

  1995cited by this paper
• Application of enzyme immunoassays for testing haemocompatibility of biomedical polymers.

  1995cited by this paper
• Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass.

  1994cited by this paper
• Platelet adhesion to fibronectin in flow: dependence on surface concentration and shear rate, role of platelet membrane glycoproteins GP IIb/IIIa and VLA-5, and inhibition by heparin.

  1994cited by this paper
• Surface-bound heparin--panacea or peril?

  1994cited by this paper
• Heparin-coated cardiopulmonary bypass circuits: hemostatic alterations and postoperative blood loss.

  1994cited by this paper
• Risk and benefit of low systemic heparinization during open heart operations.

  1994cited by this paper
• Effect of cardiopulmonary bypass on the circulating level of soluble GMP-140.

  1994cited by this paper
• Inflammatory response to cardiopulmonary bypass.

  1993cited by this paper
• Inhibition of platelet function by heparin. An etiologic factor in postbypass hemorrhage.

  1993cited by this paper
• Evidence that plasma fibrinogen and platelet membrane GPIIb-IIIa are involved in the adhesion of platelets to an artificial surface exposed to plasma.

  1993influential reference
• On the Mechanism of Coagulation Inhibition on Surfaces with End Point Immobilized Heparin

  1993cited by this paper
• Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass.

  1993cited by this paper
• Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study.

  1992cited by this paper
• Principles of heparin-coating techniques

  1991cited by this paper
• Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, adenosine diphosphate, or an in vivo wound.

  1991cited by this paper
• Biocompatibility of extracorporeal circulation. In vitro comparison of heparin-coated and uncoated oxygenator circuits.

  1991cited by this paper
• Examination of the roles of glycoprotein Ib and glycoprotein IIb/IIIa in platelet deposition on an artificial surface using clinical antiplatelet agents and monoclonal antibody blockade.

  1991cited by this paper
• Interaction of heparin with fibronectin and isolated fibronectin domains.

  1990cited by this paper
• Haemostatic changes during cardiopulmonary bypass

  1990cited by this paper
• Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb:IIIa are all involved in platelet adhesion to fibrin in flowing whole blood.

  1990cited by this paper
• The mechanism of heparin‐induced platelet aggregation

  1989cited by this paper
• Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation.

  1989cited by this paper
• Characterization of platelet binding of heparins and other glycosaminoglycans.

  1988cited by this paper
• The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium.

  1987cited by this paper
• Antithrombin III Binding to Surface Immobilized Heparin and Its Relation to F Xa Inhibition

  1987cited by this paper
• Thrombin-induced changes in platelet membrane glycoproteins Ib, IX, and IIb-IIIa complex.

  1987cited by this paper
• Thrombin inactivation on surfaces with covalently bonded heparin.

  1986cited by this paper
• Platelet attachment and spreading on polystyrene surfaces: dependence on fibronectin and plasma concentration.

  1985cited by this paper
• Catalytic activity and platelet reactivity of heparin covalently bonded to surfaces.

  1985cited by this paper
• Hemostasis Changes During Cardiopulmonary Bypass Surgery

  1985cited by this paper
• Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.

  1984cited by this paper
• Effect of heparin on platelet aggregation

  1984cited by this paper
• Complement and the damaging effects of cardiopulmonary bypass.

  1983cited by this paper
• A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue.

  1983cited by this paper
• Deposition of fibronectin on material surfaces exposed to plasma: Quantitative and biological studies

  1983cited by this paper
• Complement and the damaging effects of cardiopulmonary bypass.

  1983cited by this paper
• Effect of heparin and heparin fractions on platelet aggregation.

  1980cited by this paper
• Platelet and plasma coagulation compatibility of heparinized and sulphated surfaces.

  1979cited by this paper
• Anticoagulant and platelet aggregating activities of heparin

  1973cited by this paper

• Evaluation of an Oxygenator in the EXTra-Uterine Environment for Neonatal Development (EXTEND) System Without Systemic Anticoagulation.

  2025cites this paper
• An endothelium membrane mimetic antithrombotic coating enables safer and longer extracorporeal membrane oxygenation application.

  2024cites this paper
• Mesenchymal stem cells-based therapies for severe ARDS with ECMO: a review

  2024cites this paper
• Potential Use of Electrospun Poly(ethylene terephthalate)/Carbon Nanotubes Containing Aspirin in Vascular Tissue Engineering Application

  2023cites this paper
• Impact of surface coating and systemic anticoagulants on hemostasis and inflammation in a human whole blood model

  2023cites this paper
• Tyramine-enhanced zwitterion hyaluronan hydrogel coating for anti-fouling and anti-thrombosis

  2022cites this paper
• Activity of anticoagulant proteins on the polymer-coated and heparin-coated membranes in an extracorporeal circulation circuit

  2022cites this paper
• Polymeric Hollow Fiber Membrane Oxygenators as Artificial Lungs: A Review

  2022cites this paper
• Oxygenation and Membrane Oxygenators: Emergence, Evolution and Progress in Material Development and Process Enhancement for Biomedical Applications

  2021cites this paper
• Membrane bioreactors for (bio-)artificial lung

  2020cites this paper
• Evaluation of Different Dialyzers and the Impact of Predialysis Albumin Priming in Intermittent Hemodialysis With Reduced Anticoagulation

  2019cites this paper
• Techniques for modifying biomaterials to improve hemocompatibility

  2018cites this paper
• A study on a novel continuous blood viscosity monitoring method for cardiopulmonary bypass

  2017cites this paper
• Endothelialization and characterization of titanium dioxide-coated gas-exchange membranes for application in the bioartificial lung.

  2017cites this paper
• Sulfated Alginates as Heparin Analogues: A Review of Chemical and Functional Properties

  2017cites this paper
• RETRACTED: Do phosphorylcholine-coated and uncoated oxygenators differ in terms of elicitation of cellular immune response during cardiopulmonary bypass surgery?

  2017cites this paper
• Continuous Blood Viscosity Monitoring System for Cardiopulmonary Bypass Applications

  2017cites this paper
• Rough Wetting . ” ( Continued ) Primary Examiner —

  2017cites this paper
• United States Patent Aizenberg

  2017cites this paper
• Bivalirudin as an adjunctive anticoagulant to heparin in the treatment of heparin resistance during cardiopulmonary bypass-assisted cardiac surgery

  2016cites this paper
• Humoral immune response and coated or uncoated oxygenators during cardiopulmonary bypass surgery

  2016cites this paper
• Multimodal, Biomaterial‐Focused Anticoagulation via Superlow Fouling Zwitterionic Functional Groups Coupled with Anti‐Platelet Nitric Oxide Release

  2016cites this paper
• Hemocompatibility and film stability improvement of crosslinkable MPC copolymer coated polypropylene hollow fiber membrane

  2014cites this paper
• Computational evaluation of the thrombogenic potential of a hollow-fiber oxygenator with integrated heat exchanger during extracorporeal circulation

  2014cites this paper
• Successful treatment of pulmonary contusion following chest trauma using poly‐2‐methoxyethyl acrylate, a biocompatible polymer surface coating for extracorporeal membrane oxygenation

  2014cites this paper
• Antifouling Silicone Coatings Prepared with PEO-Silane Amphiphiles

  2014cites this paper
• Human albumin in extracorporeal prime: effect on platelet function and bleeding

  2013cites this paper
• Nitric oxide therapies for local inhibition of platelets' activitation on blood-contacting surfaces

  2011cites this paper
• Surface modification of biomaterials by heparinisation to improve blood compatibility

  2011cites this paper
• Activation of the Hemostatic System During Cardiopulmonary Bypass

  2011cites this paper
• A lubricious formulation exhibiting reduced thrombogenicity, cell proliferation, and protein adsorption.

  2009cites this paper
• CD41 Western blotting: a new method to detect platelet adhesion to artificial surfaces used in extracorporeal circulation procedures

  2009cites this paper
• Novel thrombo-resistant coating based on iron-polysaccharide complex multilayers.

  2009cites this paper
• When Blood Is Touched

  2009cites this paper
• Surface engineering of macroporous polypropylene membranes

  2009cites this paper
• Antithrombogenicity of Hydromer's polymeric formula F202 immobilized on polyurethane and electropolished stainless steel.

  2008cites this paper
• Efficiency in Extracorporeal Membrane Oxygenation—Cellular Deposits on Polymethypentene Membranes Increase Resistance to Blood Flow and Reduce Gas Exchange Capacity

  2008cites this paper
• Untersuchungen zur Hämokompatibilität von biopassiven Oberflächenbeschichtungen

  2007cites this paper
• Development of a Paracorporeal Respiratory Assist Lung (PRAL)

  2007cites this paper
• A new oxygenator change-out system and procedure

  2006cites this paper
• Is hypothermia a benefit? Von Willebrand factor in pediatric cardiopulmonary bypass.

  2006cites this paper
• Pump-induced platelet aggregation with subsequent hypotension: Its mechanism and prevention with clopidogrel.

  2006cites this paper
• Development of a biohybrid lung

  2006cites this paper
• Strategies to reduce hemostatic activation during cardiopulmonary bypass.

  2006cites this paper
• The kinetics of plasmin inhibition by aprotinin in vivo.

  2005cites this paper
• Clinical performance and biocompatibility of novel hyaluronan-based heparin-bonded extracorporeal circuits.

  2005cites this paper
• Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass.

  2005cites this paper
• Plasmin generation and D-dimer formation during cardiopulmonary bypass

  2004cites this paper
• Plasmin generation and D-dimer formation during cardiopulmonary bypass.

  2004cites this paper
• Analysis of cellular morphology, adhesion, and proliferation on uncoated and differently coated PVC tubes used in extracorporeal circulation (ECC).

  2004cites this paper
• Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1299 Monocytes, Tissue Factor and Heparin-coated Surfaces Clinical and Experimental Studies

  2003cites this paper
• Monocytes, Tissue Factor and Heparin-coated Surfaces : Clinical and Experimental Studies

  2003cites this paper
• Cell Adhesion and Tissue Factor Upregulation in Oxygenators used during Coronary Artery Bypass Grafting are Modified by the Corline Heparin Surface

  2002cites this paper
• Case 7--2001. Management during cardiopulmonary bypass of patients with presumed fish allergy.

  2001cites this paper
• Update on cardiopulmonary bypass

  2001cites this paper
• Effect of Carmeda® BioActive Surface coating versus Trillium™ Biopassive Surface coating of the oxygenator on circulating platelet count drop during cardiopulmonary bypass

  2001cites this paper
• Efficacy of a new coating material, PMEA, for cardiopulmonary bypass circuits in a porcine model.

  2001cites this paper
• Platelet Adhesion to Heparin Coated Oxygenator Fibers Under In Vitro Static Conditions: Impact of Temperature

  2001cites this paper